Highly sensitive alpha‐fetoprotein,Lens culinarisagglutinin‐reactive fraction of alpha‐fetoprotein and des‐gamma‐carboxyprothrombin for hepatocellular carcinoma detection
- 6 July 2015
- journal article
- research article
- Published by Wiley in Hepatology Research
- Vol. 46 (3) , E130-E135
Abstract
Aim: Hepatocellular carcinoma (HCC) develops with high incidence in patients with chronic liver disease (CLD), and particularly in those with cirrhosis. Currently, diagnosis and surveillance are mainly based on imaging methods. The aim of this study was to evaluate the diagnostic accuracy of highly sensitive measurement of α‐fetoprotein (AFP),Lens culinarisagglutinin‐reactive fraction of AFP (AFP‐L3) and des‐γ‐carboxyprothrombin (DCP) alone and in combination, for HCC detection. In addition, a recently proposed statistical model, including these three biomarkers plus sex and age, the GALAD model, was applied.Methods: In a total of 98 patients (44 CLD patients without HCC [23 men, 21 women; mean age, 53.2 ± 13.4 years] and 54 patients with HCC [45 men, nine women; 69.5 ± 9.8 years]), AFP, AFP‐L3 and DCP levels were determined using a highly sensitive assay on an μTASWako i30 immuno‐analyzer. Areas under the curve (AUC), sensitivity and specificity were calculated and compared to assess diagnostic performance of the HCC biomarkers and of the GALAD model.Results: AFP, AFP‐L3 and DCP serum levels were significantly elevated in HCC compared with CLD patients (P < 0.0001). AUC values were 0.891, 0.867 and 0.870, respectively. The combination of the three biomarkers resulted in an AUC of 0.947, whereas the GALAD model showed an AUC of 0.976 with a difference between AUC values of 0.029 (P = 0.028).Conclusion: The combination of AFP, AFP‐L3 and DCP is superior to a single biomarker in HCC detection. Furthermore, GALAD model performance is significantly higher than simple combination of these three biomarkers.Keywords
This publication has 22 references indexed in Scilit:
- Highly Sensitive Lens culinaris Agglutinin-Reactive α-Fetoprotein: A New Tool for the Management of Hepatocellular CarcinomaOncology, 2011
- Highly sensitive AFP‐L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre‐ and postoperativelyHepatology Research, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)Hepatology Research, 2010
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosisAlimentary Pharmacology & Therapeutics, 2009
- Automated immunoassay system for AFP–L3% using on-chip electrokinetic reaction and separation by affinity electrophoresisAnalytical Biochemistry, 2009
- Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver DiseaseGastroenterology, 2009
- Incidence and Predictors of Hepatocellular Carcinoma in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2007